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Opinion  
Benzimidazole is one of the oldest known nitrogen heterocycles. It is a bicyclic ring made up by fusion of 
benzene to 4, 5 position of imidazole and also known as benzoglyoxaline or benziminazole. It was first 
synthesized by Hoebrecker and afterward by Ladenberg and Wundt during 1872–1878. [1–3] and received 
attention since 1950s. [4-7] Heterocycles play an essential role in the field of organic and medicinal or 
pharmaceutical chemistry. Especially, nitrogen heterocycles display a broad range of biological activities because 
of similarities with many naturally occurring products such as α-amino acid histidine, purine, histamine, and 
biotin. These are useful scaffolds for the development of drug and active pharmaceutical ingredients (API). Such 
molecules can easily interact with biomolecules within the living systems because of the structural similarity and 
show their desired effects. [8]. Substituted benzimidazole derivatives have been used in various applications of 
biological interest such as anticancer agents, analgesic agents, antiulcer, and anthelmintic, anti-inflammatory, 
antibacterial, antifungal, antioxidant, anti-HIV, antitubercular, anticonvulsant, antileishmanial, antidiabetic, 
antimalarial, antihistaminic agents, topoisomerase I inhibitors [9],  angiotensin II inhibitors [10], selective 
neuropeptide Y1 receptor antagonists [10], inhibitors of HCMV replication [11], dipeptidyl peptidase IV inhibitors 
[12] and inhibitors of the hepatitis C virus RNA polymerase. [13] Moreover, some benzimidazole derivatives 
exhibited significant activity against RNA [14], herpes (HSV-1) [15], human cytomegalovirus (HCMV) [16], and 
influenza. [17] There is a very long list of benzimidazole derivatives which are actively used in pharmaceutical 
industry and some of them are mentioned here as omeprazole (1), triclabendazole (2), pimobendan (3), 
oxfendazole (4), flubendazole (5), mebendazole (6), fenbendazole (7), albendazole (8), parbendazole (9), 
oxibendazole (10), luxabendazole (11), thiabendazole (12) and cambendazole (13). (Figure 1) There are various 
effective anticancer drugs which are used to treat several types of cancers, eg. Nocodazole, bendamustine, 
veliparp and carbendazim. 
 
Figure 1. Some bioactive benzimidazole containing drugs. 
Alzheimer’s disease is a neurodegenerative disorder of the brain characterized by progressive 
neurodegeneration, memory loss, impairment in cognition and ultimately leading to death of the patient [18]. 
To tackle with this disease, it is important to design new multitarget drugs for Alzheimer’s disease rather than 
single-target drugs. A. S. Alpan et al. reported the synthesis of Mannich bases of benzimidazole derivatives 
having phenolic group and evaluated for their possible in vitro antioxidant and AChE/BuChE inhibitory 
potentials. [19] Te-Mao Li et al. reported the synthesis of novel benzimidazole derivative, which induced cell 
apoptosis in human chondrosarcoma tumor cells. [20] Ju-Fang Liu et al. studied the anticancer effects of a new 
benzimidazole derivative, 2-(furanyl)-5-(piperidinyl)-(3,4,5-trimethoxybenzyl)benzimidazole which also induced 
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apoptosis in human chondrosarcoma cell lines (SW1353 and JJ012) and thus may prove a potential anticancer 
agent for the treatment of this bone tumor. [21] A. Rathore et al. synthesized new benzimidazole derivatives 
endowed with oxadiazole and investigated for selective cyclooxygenase (COX-2) inhibitor activity. [22] 
Therefore, the benzimidazole nucleus has gained attention to synthetic organic chemists for the synthesis of 
various bioactive compounds. 
In addition of displaying a wide array of pharmaceutical properties, benzimidazole moiety has great potential 
of showing some other diverse properties as well such as bioimaging, water sorption, gas sorption, and 
electrochemical properties. Transition metal ions are essential for the normal growth and fundamental 
physiological processes within the body in trace quantity. But when they are taken in excess amount, they may 
prove fatal for the organism. For instance, excess Cu2+ ion concentration in the body can cause 
neurodegenerative diseases such as Alzheimer, Menkes, and Parkinson. [23] Hence, their detection in the living 
systems at lower concentration becomes very important. Several techniques such as atomic absorption 
spectrometry, coupled plasma atomic emission spectrometry and electrochemical 
method has been used to detect the metal ions [24], but they are associated with some limitations like on-site 
detection. Now a days, fluorescent chemosensors, mainly synthesized from benzimidazole moiety, are utilized 
to detect the metal ions due to their high sensitivity and selectivity, fast response, on‐site monitoring, and lower 
cost. [25] The transition metal complexes derived from benzimidazole have also been observed to exhibit 
catalytic activity in various transformations. In this context, B. Cetinkaya et al. synthesized Rhodium complexes 
of benzimidazole and investigated the catalytic activity in the intramolecular cyclization of (Z)‐3‐methylpent‐2‐
en‐4‐yn‐1‐ol into 2,3‐dimethylfuran in good yield. [26] Water-soluble benzimidazole containing ionic 
palladium(II) complex have also been reported for rapid microwave-assisted Suzuki reaction of aryl chlorides. 
[27] The polyamides containing a benzimidazole moiety were reported to exhibit the water sorption properties. 
[28] The probe made from benzimidazole derivative can also detect water at trace level as impurity in organic 
solvents by colorimetric and fluorescence method. [29] Y. Cui et al. reported the gas sorption properties of 
porous benzimidazole-linked polymers possessing excellent applications of gas storage. [30] Similarly, R. 
Muhammad also synthesized an imine and benzimidazole functionalized nanoporous polymer which had good 
selectivity of CO2 over N2. [31] Benzimidazole derivatives have also been shown physical, optical and 
electrochemical properties e.g. the electrochemical studies of myoglobin were carried out by using 
benzimidazole modified silver electrode [32] and fabrication of OLED devices. [33]  
Therefore, I must say that benzimidazole is an established multifunctional scaffold with their vast biological 
applications. The author of this article keeps engaged in drug research and has published various papers on 
antibacterial, antifungal, and anticancer drug discovery. The continuous R & D in the field of synthesis and 
pharmacological activity of benzimidazole derivatives is continuously going on. Hence, the researchers are 
constantly putting their endeavours to find out more effective drugs derived from benzimidazole, but their 
efforts are still to go miles for wellness and betterment of human life. 
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